272 related articles for article (PubMed ID: 29134313)
1. Long-Term Outcome After Surgery for Medullary Thyroid Carcinoma: A Single-Center Experience.
Torresan F; Cavedon E; Mian C; Iacobone M
World J Surg; 2018 Feb; 42(2):367-375. PubMed ID: 29134313
[TBL] [Abstract][Full Text] [Related]
2. Long-Term Outcomes and Aggressiveness of Hereditary Medullary Thyroid Carcinoma: 40 Years of Experience at One Center.
Raue F; Bruckner T; Frank-Raue K
J Clin Endocrinol Metab; 2019 Oct; 104(10):4264-4272. PubMed ID: 31145454
[TBL] [Abstract][Full Text] [Related]
3. Medullary thyroid carcinoma: clinical characteristics, treatment, prognostic factors, and a comparison of staging systems.
Kebebew E; Ituarte PH; Siperstein AE; Duh QY; Clark OH
Cancer; 2000 Mar; 88(5):1139-48. PubMed ID: 10699905
[TBL] [Abstract][Full Text] [Related]
4. Long term prognosis of medullary thyroid carcinoma in 39 patients.
Voutilainen PE; Multanen M; Haapiainen RK; Haglund CH; Sane T; Sivula AH
Ann Chir Gynaecol; 2000; 89(4):292-7. PubMed ID: 11204961
[TBL] [Abstract][Full Text] [Related]
5. Similar Stage-dependent Survival and Outcome in Sporadic and Hereditary Medullary Thyroid Carcinoma.
Raue F; Bruckner T; Frank-Raue K
J Clin Endocrinol Metab; 2021 Aug; 106(9):e3582-e3591. PubMed ID: 33974051
[TBL] [Abstract][Full Text] [Related]
6. Survival and Long-Term Biochemical Cure in Medullary Thyroid Carcinoma in Denmark 1997-2014: A Nationwide Study.
Mathiesen JS; Kroustrup JP; Vestergaard P; Stochholm K; Poulsen PL; Rasmussen ÅK; Feldt-Rasmussen U; Schytte S; Londero SC; Pedersen HB; Hahn CH; Bentzen J; Möller S; Gaustadnes M; Rossing M; Nielsen FC; Brixen K; Frederiksen AL; Godballe C
Thyroid; 2019 Mar; 29(3):368-377. PubMed ID: 30618340
[TBL] [Abstract][Full Text] [Related]
7. Long-term clinical and biochemical follow-up in medullary thyroid carcinoma: a single institution's experience over 20 years.
Cupisti K; Wolf A; Raffel A; Schott M; Miersch D; Yang Q; Eisenberger CF; Röher HD; Knoefel WT
Ann Surg; 2007 Nov; 246(5):815-21. PubMed ID: 17968174
[TBL] [Abstract][Full Text] [Related]
8. Surgical strategy for the treatment of sporadic medullary thyroid carcinoma: our experience.
Lupone G; Antonino A; Rosato A; Zenone P; Iervolino EM; Grillo M; De Palma M
G Chir; 2012; 33(11-12):395-9. PubMed ID: 23140924
[TBL] [Abstract][Full Text] [Related]
9. Predicting Outcomes in Sporadic and Hereditary Medullary Thyroid Carcinoma over Two Decades.
Kotwal A; Erickson D; Geske JR; Hay ID; Castro MR
Thyroid; 2021 Apr; 31(4):616-626. PubMed ID: 33108969
[No Abstract] [Full Text] [Related]
10. Prognostic variables and calcitonin in medullary thyroid cancer.
Clark JR; Fridman TR; Odell MJ; Brierley J; Walfish PG; Freeman JL
Laryngoscope; 2005 Aug; 115(8):1445-50. PubMed ID: 16094121
[TBL] [Abstract][Full Text] [Related]
11. Prognostic factors for survival and for biochemical cure in medullary thyroid carcinoma: results in 899 patients. The GETC Study Group. Groupe d'étude des tumeurs à calcitonine.
Modigliani E; Cohen R; Campos JM; Conte-Devolx B; Maes B; Boneu A; Schlumberger M; Bigorgne JC; Dumontier P; Leclerc L; Corcuff B; Guilhem I
Clin Endocrinol (Oxf); 1998 Mar; 48(3):265-73. PubMed ID: 9578814
[TBL] [Abstract][Full Text] [Related]
12. A Nationwide Study of Multiple Endocrine Neoplasia Type 2A in Norway: Predictive and Prognostic Factors for the Clinical Course of Medullary Thyroid Carcinoma.
Opsahl EM; Brauckhoff M; Schlichting E; Helset K; Svartberg J; Brauckhoff K; Mæhle L; Engebretsen LF; Sigstad E; Grøholt KK; Akslen LA; Jørgensen LH; Varhaug JE; Bjøro T
Thyroid; 2016 Sep; 26(9):1225-38. PubMed ID: 27400880
[TBL] [Abstract][Full Text] [Related]
13. Cure and survival of sporadic medullary thyroid carcinoma following systematic preoperative calcitonin screening.
Torresan F; Mian C; Cavedon E; Iacobone M
Langenbecks Arch Surg; 2019 Jun; 404(4):411-419. PubMed ID: 30903267
[TBL] [Abstract][Full Text] [Related]
14. Clinico-pathologic and dynamic prognostic factors in sporadic and familial medullary thyroid carcinoma: an Israeli multi-center study.
Twito O; Grozinsky-Glasberg S; Levy S; Bachar G; Gross DJ; Benbassat C; Rozental A; Hirsch D
Eur J Endocrinol; 2019 Jul; 181(1):13-21. PubMed ID: 31048559
[TBL] [Abstract][Full Text] [Related]
15. Different outcomes in sporadic versus familial medullary thyroid cancer.
Saltiki K; Simeakis G; Anagnostou E; Zapanti E; Anastasiou E; Alevizaki M
Head Neck; 2019 Jan; 41(1):154-161. PubMed ID: 30548085
[TBL] [Abstract][Full Text] [Related]
16. Natural history, diagnosis, treatment and outcome of medullary thyroid cancer: 37 years experience on 157 patients.
Pelizzo MR; Boschin IM; Bernante P; Toniato A; Piotto A; Pagetta C; Nibale O; Rampin L; Muzzio PC; Rubello D
Eur J Surg Oncol; 2007 May; 33(4):493-7. PubMed ID: 17125960
[TBL] [Abstract][Full Text] [Related]
17. Static Prognostic Factors and Appropriate Surgical Designs for Patients with Medullary Thyroid Carcinoma: The Second Report from a Single-Institution Study in Japan.
Ito Y; Miyauchi A; Kihara M; Higashiiyama T; Fukushima M; Miya A
World J Surg; 2018 Dec; 42(12):3954-3966. PubMed ID: 30051240
[TBL] [Abstract][Full Text] [Related]
18. Medullary thyroid cancer: clinico-pathological profile and outcome in a tertiary care center in North India.
Mehrotra PK; Mishra A; Mishra SK; Agarwal G; Agarwal A; Verma AK
World J Surg; 2011 Jun; 35(6):1273-80. PubMed ID: 21479684
[TBL] [Abstract][Full Text] [Related]
19. Medullary Thyroid Carcinoma: Survival Analysis and Evaluation of Mutation-Specific Immunohistochemistry in Detection of Sporadic Disease.
Jayakody S; Reagh J; Bullock M; Aniss A; Clifton-Bligh R; Learoyd D; Robinson B; Delbridge L; Sidhu S; Gill AJ; Sywak M
World J Surg; 2018 May; 42(5):1432-1439. PubMed ID: 29484475
[TBL] [Abstract][Full Text] [Related]
20. Medullary carcinoma of the thyroid gland and the MEN 2 syndromes.
Skinner MA; Wells SA
Semin Pediatr Surg; 1997 Aug; 6(3):134-40. PubMed ID: 9263335
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
